Microbot Medical Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Microbot Medical Inc. on February 19, 2026. The report discloses a corporate event under Item 7.01 (Regulation FD Disclosure) regarding the participation of company leadership at an industry summit.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a specific event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled speaking engagement.
Guidance, Outlook, and Management Commentary
On February 19, 2026, the Company issued a press release (Exhibit 99.1) announcing that Harel Gadot, CEO, President, and Chairman, will serve as a featured panelist at The Surgical Disruptive Technology Summit. This event is part of the SAGES NBT Innovation Weekend, held from February 19-21, 2026, in Houston, TX. The information is furnished and not deemed "filed" for liability purposes under Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the panel discussion.
- Confirm the date and location of the SAGES NBT Innovation Weekend (February 19-21, 2026, Houston, TX).
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.